Cascade Corp Stock Price (NASDAQ:CASC)

Add to My Stocks
$4.31 $0.02 (0.46%) CASC stock closing price Feb 21, 2017 (Closing)
Prev Close* : $4.33
Market Cap:
Day Low: $4.25
52 Week Low: $3.49
Open: $4.38
Volume: 163031
Day High: $4.4
52 Week High: $10.98

Latest Stock Market News

Latest Articles

CASC Stockcharts

View CASC PE ratio, PS ratio stocks charts and compare with peers.
CASC Chart
Note: Compare Cascade Corp stock price history with the index and industry peers.

Cascade Corp Financial Ratios

Debt to Equity

CASC Industry Peers

Company Price Change (%)
Synthetic Biologics (SYN)0.790.02 (2.47%)
Peregrine Pharma (PPHM)0.480.07 (12.73%)
Puma Biotech (PBYI)38.351.9 (4.72%)
Macrogenics (MGNX)20.520.87 (4.07%)
Array Biopharma (ARRY)10.880.49 (4.31%)
Merrimack Pharma (MACK)3.160.02 (0.63%)
Agenus (AGEN)4.540.03 (0.67%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
EXACT Sciences (EXAS)22.412.5 (12.56%)
Fate Therapeutics (FATE)4.380.45 (11.45%)
Nymox Pharmaceutical (NYMX)3.540.12 (3.51%)
Myriad Genetics (MYGN)19.080.46 (2.47%)
Stemline Therapeutics (STML)6.950.15 (2.21%)
Evogene (EVGN)5.4210.11 (2.07%)
OncoMed Pharma (OMED)8.910.18 (2.06%)
Top gainers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Feb 21, 2017
CompanyPriceChange (%)
Trevena (TRVN)4.272.86 (40.11%)
Momenta Pharma (MNTA)16.052.95 (15.53%)
Peregrine Pharma (PPHM)0.4790.07 (12.73%)
Cytokinetics (CYTK)10.40.85 (7.56%)
Argos Therapeutics (ARGS)4.40.3 (6.38%)
Sorrento Therapeutics (SRNE)5.250.3 (5.41%)
Immunomedics (IMMU)5.060.28 (5.24%)
Top losers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Feb 21, 2017

Cascade Corp Financial Statements

income statement20152014201320122011
Net Sales Or Revenues----0.14M
Net Income-32.58M-49.96M-38.75M-3.41M-42.65M
Total Operating Expense32.78M50.83M41.22M28.49M24.83M
view Cascade Corporation income statement
balance sheet20152014201320122011
Total Assets96.57M103.41M77.74M89.43M71.35M
Total Liabilities12.83M12.14M6.19M7.11M37.91M
Shareholders Equity83.73M91.26M71.55M82.32M33.43M
view Cascade Corporation balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities0.27M-0.74M1.64M-0.25M1.4M
Net Cash From (Used By) Operating Activities-28.87M-48.36M-36.34M-27.33M-21M
Increase (Decrease) In Prop Plant And Equipment-0.77M-0.38M-0.25M-0.75M-0.14M
view Cascade Corporation cashflow statement

Cascade Corporation Stock News - Partner Headlines

Cascade Corp Stock Message Board

As of last trading day, Cascade Corp stock price was 4.33. Looking at Cascade Corp market capitalization, which currently stands at 97.7M, we can say that CASC stock is a Micro cap stock. A value investor must look at the fundamentals of a stock, and perform Cascade Corp valuation, even though in the short-term sentiment and current breaking news might affect Cascade Corp stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy CASC stock than sell it, then Cascade Corp stock price goes up. Conversely, if more investors wanted to sell CASC stock than buy it, there would be greater supply than demand, and the stock price would fall. 221719 shares were traded with a closing stock price of 4.33 as of 17 Feb, 2017, as can be seen from Cascade Corp stock quote. One can view Cascade Corp stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of CASC, view Cascade Corp stock price history.

Related to Cascade Corp Stock Quotes

Cascade Corp stock price history, Cascade Corp stock chart